Status:
COMPLETED
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Functional Dyspepsia
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Functional Dyspepsia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Objective: To observe the effect of the treatment of transcutaneous auricular vagus nerve stimulation (taVNS) for the functional dyspepsia (FD). Methods: We accrued 94 patients at Beijing TongRen Hos...
Eligibility Criteria
Inclusion
- 1\. Age \>=18 and Age \<=65. 2. Clinical diagnosis of functional dyspepsia.
Exclusion
- 1\. History of depression, tumors, thyroid disease, diabetes, cardiac diseases. 2. History of gastrointestinal surgery. 3. Pregnant or lactating women.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04706871
Start Date
July 1 2018
End Date
January 1 2020
Last Update
January 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tongren Hospital
Beijing, China